Senate LDA lobbying filing

Pfizer Inc.

A public disclosure record: who filed, what they reported, and the program connections found in the text.

Reported amounts Program mentions Activity text Lobbyists

Registrant: NVG, LLC Year: 2024 Period: First Quarter Type: Q1

Filed as: PFIZER INC. — NVG, LLC. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Prescription drug coverage and payment policies. Issues related to pharmaceutical supply chain transparency and…

Lobbying activities2

Copyright/Patent/TrademarkCPT
Intellectual property, data exclusivity, and patent eligibility.
Health IssuesHCR
Prescription drug coverage and payment policies. Issues related to pharmaceutical supply chain transparency and integrity. 340B legislation. Issues related to vaccine injury compensation funds.

Lobbyists4

ANDREA LARUE
BRADY KING
EDEN SHIFERAW
LISA FOSTER

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.